These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30334933)

  • 21. [Preparation and quality control of pyridostigmine bromide orally disintegrating tablet].
    Zhang L; Tan QY; Cheng XG; Wang H; Hu NN; Zhang JQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):458-61, 477. PubMed ID: 22812258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy.
    Ceron RH; Báez-Cruz FA; Palmer NJ; Carman PJ; Boczkowska M; Heuckeroth RO; Ostap EM; Dominguez R
    Sci Adv; 2024 May; 10(22):eadn6615. PubMed ID: 38820162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridostigmine in chronic intestinal pseudo-obstruction - a systematic review.
    Wilkie BD; Noori J; Johnston M; Woods R; Keck JO; Behrenbruch C
    ANZ J Surg; 2023 Sep; 93(9):2086-2091. PubMed ID: 37132128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of botulinum toxin-induced eyelid ptosis with anticholinesterases.
    Karami M; Taheri A; Mansoori P
    Dermatol Surg; 2007 Nov; 33(11):1392-4 discussion 1394-5. PubMed ID: 17958599
    [No Abstract]   [Full Text] [Related]  

  • 25. Overlooked myasthenia gravis in an elderly adult.
    Jiang L; Wu W; Guan W; Wu Z; Nie Y
    J Am Geriatr Soc; 2013 May; 61(5):840-1. PubMed ID: 23672558
    [No Abstract]   [Full Text] [Related]  

  • 26. Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.
    Sandroni P; Opfer-Gehrking TL; Singer W; Low PA
    Clin Auton Res; 2005 Feb; 15(1):51-3. PubMed ID: 15768203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyridostigmine-induced microcephaly.
    Niesen CE; Shah NS
    Neurology; 2000 May; 54(9):1873-4. PubMed ID: 10802806
    [No Abstract]   [Full Text] [Related]  

  • 28. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ACTG2 associated visceral myopathy with intestinal pseudoobstruction].
    Shen MX; Zhao C; Wang YJ; Xin XW; Yin Y; Jin YP
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):331-333. PubMed ID: 33775056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of CHOPi012-A iPSC line from a patient with visceral myopathy-related chronic intestinal pseudo-obstruction.
    Hashmi SK; Schneider S; Gagne AL; Maguire JA; Gadue P; Heuckeroth RO; French DL
    Stem Cell Res; 2023 Sep; 71():103176. PubMed ID: 37572398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
    Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
    Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
    Stam M; Wadman RI; Wijngaarde CA; Bartels B; Asselman FL; Otto LAM; Goedee HS; Habets LE; de Groot JF; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    BMJ Open; 2018 Jul; 8(7):e019932. PubMed ID: 30061431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).
    Tuzovic L; Tang S; Miller RS; Rohena L; Shahmirzadi L; Gonzalez K; Li X; LeDuc CA; Guo J; Wilson A; Mills A; Glassberg K; Rotterdam H; Sepulveda AR; Zeng W; Chung WK; Anyane-Yeboa K
    Fetal Diagn Ther; 2015; 38(4):296-306. PubMed ID: 25998219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of peripheral cholinergic stimulation on autonomic modulation in Type 2 diabetes with autonomic neuropathy: a randomized controlled trial.
    Harthmann AD; Souza WI; Ferlin EL; Moraes RS
    Diabet Med; 2014 Jun; 31(6):761-2. PubMed ID: 24588362
    [No Abstract]   [Full Text] [Related]  

  • 35. A suspect antidote. Did nerve-gas pill cause ailments?
    Morris J
    US News World Rep; 1999 Nov; 127(17):73. PubMed ID: 10623300
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of acute and repeated pyridostigmine bromide administration on response acquisition with immediate and delayed reinforcement.
    van Haaren F; De Jongh R; Hoy JB; Karlix JL; Schmidt CJ; Tebbett IR; Wielbo D
    Pharmacol Biochem Behav; 1999 Feb; 62(2):389-94. PubMed ID: 9972708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription profile of pyridostigmine use in a population of patients with myasthenia gravis.
    Machado-Alba JE; Calvo-Torres LF; Gaviria-Mendoza A; Augusto MejíA-Vélez C
    Muscle Nerve; 2017 Dec; 56(6):1041-1046. PubMed ID: 28214292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudo-obstruction-inducing ACTG2R257C alters actin organization and function.
    Hashmi SK; Barka V; Yang C; Schneider S; Svitkina TM; Heuckeroth RO
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pyridostigmine in the treatment of postural orthostatic tachycardia syndrome].
    Can I; Tholakanahalli V
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):553-5. PubMed ID: 25362946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A woman from Kenosha.
    Gutmann L
    Neurology; 2017 Jan; 88(2):214-215. PubMed ID: 28069973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.